{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2", "Syzygium aromaticum", "clove", "coronavirus infections", "eugeniin", "eugenol", "herbal medicine", "natural compounds", "pandemics", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33810416", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "26"}], "Language": ["eng"], "ELocationID": ["1880", "10.3390/molecules26071880"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Mar", "Day": "26"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Molecular Basis of the Therapeutical Potential of Clove (<i>Syzygium aromaticum</i> L.) and Clues to Its Anti-COVID-19 Utility.", "Abstract": {"AbstractText": ["The current COronaVIrus Disease 19 (COVID-19) pandemic caused by SARS-CoV-2 infection is enormously affecting the worldwide health and economy. In the wait for an effective global immunization, the development of a specific therapeutic protocol to treat COVID-19 patients is clearly necessary as a short-term solution of the problem. Drug repurposing and herbal medicine represent two of the most explored strategies for an anti-COVID-19 drug discovery. Clove (<i>Syzygium aromaticum</i> L.) is a well-known culinary spice that has been used for centuries in folk medicine in many disorders. Interestingly, traditional medicines have used clove since ancient times to treat respiratory ailments, whilst clove ingredients show antiviral and anti-inflammatory properties. Other interesting features are the clove antithrombotic, immunostimulatory, and antibacterial effects. Thus, in this review, we discuss the potential role of clove in the frame of anti-COVID-19 therapy, focusing on the antiviral, anti-inflammatory, and antithrombotic effects of clove and its molecular constituents described in the scientific literature."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istituto di Biostrutture e Bioimmagini IBB-CNR, Via Tommaso De Amicis 95, 80145 Naples, Italy."}], "LastName": "Vicidomini", "ForeName": "Caterina", "Initials": "C"}, {"Identifier": ["0000-0001-7340-8101"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Materials and Industrial Production Engineering (DICMaPI), University of Naples Federico II, Piazzale V. Tecchio 80, 80125 Naples, Italy."}], "LastName": "Roviello", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": ["0000-0001-6065-2367"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Istituto di Biostrutture e Bioimmagini IBB-CNR, Via Tommaso De Amicis 95, 80145 Naples, Italy."}], "LastName": "Roviello", "ForeName": "Giovanni N", "Initials": "GN"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Fibrinolytic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["prevention & control"], "DescriptorName": "COVID-19"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fibrinolytic Agents"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Syzygium"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "V\u2019kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 2020;19:155\u2013170. doi: 10.1038/s41579-020-00468-6.", "ArticleIdList": ["10.1038/s41579-020-00468-6", "PMC7592455", "33116300"]}, {"Citation": "Chu D.K.W., Leung C.Y.H., Gilbert M., Joyner P.H., Ng E.M., Tse T.M., Guan Y., Peiris J.S.M., Poon L.L.M. Avian Coronavirus in wild aquatic birds. J. Virol. 2011;85:12815\u201312820. doi: 10.1128/JVI.05838-11.", "ArticleIdList": ["10.1128/JVI.05838-11", "PMC3209365", "21957308"]}, {"Citation": "Poon L.L.M., Chu D.K.W., Chan K.H., Wong O.K., Ellis T.M., Leung Y.H.C., Lau S.K.P., Woo P.C.Y., Suen K.Y., Yuen K.Y., et al. Identification of a novel coronavirus in bats. J. Virol. 2005;79:2001\u20132009. doi: 10.1128/JVI.79.4.2001-2009.2005.", "ArticleIdList": ["10.1128/JVI.79.4.2001-2009.2005", "PMC546586", "15681402"]}, {"Citation": "Wang L.-F., Anderson D.E. Viruses in bats and potential spillover to animals and humans. Curr. Opin. Virol. 2019;34:79\u201389. doi: 10.1016/j.coviro.2018.12.007.", "ArticleIdList": ["10.1016/j.coviro.2018.12.007", "PMC7102861", "30665189"]}, {"Citation": "Memish Z.A., Mishra N., Olival K.J., Fagbo S.F., Kapoor V., Epstein J.H., AlHakeem R., Durosinloun A., Al Asmari M., Islam A., et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 2013;19:1819\u20131823. doi: 10.3201/eid1911.131172.", "ArticleIdList": ["10.3201/eid1911.131172", "PMC3837665", "24206838"]}, {"Citation": "Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. USA. 2005;102:7988\u20137993. doi: 10.1073/pnas.0409465102.", "ArticleIdList": ["10.1073/pnas.0409465102", "PMC1142358", "15897467"]}, {"Citation": "Ye Z.-W., Yuan S., Yuen K.-S., Fung S.-Y., Chan C.-P., Jin D.-Y. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020;16:1686\u20131697. doi: 10.7150/ijbs.45472.", "ArticleIdList": ["10.7150/ijbs.45472", "PMC7098031", "32226286"]}, {"Citation": "Gossner C., Danielson N., Gervelmeyer A., Berthe F., Faye B., Kaasik Aaslav K., Adlhoch C., Zeller H., Penttinen P., Coulombier D. Human\u2013dromedary camel interactions and the risk of acquiring zoonotic middle east respiratory syndrome Coronavirus infection. Zoonoses Public Health. 2014;63:1\u20139. doi: 10.1111/zph.12171.", "ArticleIdList": ["10.1111/zph.12171", "PMC7165574", "25545147"]}, {"Citation": "Sheahan T., Rockx B., Donaldson E., Sims A., Pickles R., Corti D., Baric R. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J. Virol. 2008;82:2274\u20132285. doi: 10.1128/JVI.02041-07.", "ArticleIdList": ["10.1128/JVI.02041-07", "PMC2258931", "18094188"]}, {"Citation": "Sheahan T., Rockx B., Donaldson E., Corti D., Baric R. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J. Virol. 2008;82:8721\u20138732. doi: 10.1128/JVI.00818-08.", "ArticleIdList": ["10.1128/JVI.00818-08", "PMC2519660", "18579604"]}, {"Citation": "Gaunt E.R., Hardie A., Claas E.C.J., Simmonds P., Templeton K.E. Epidemiology and clinical presentations of the four Human Coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 2010;48:2940\u20132947. doi: 10.1128/JCM.00636-10.", "ArticleIdList": ["10.1128/JCM.00636-10", "PMC2916580", "20554810"]}, {"Citation": "Woldemeskel B.A., Kwaa A.K., Garliss C.C., Laeyendecker O., Ray S.C., Blankson J.N. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. J. Clin. Investig. 2020;130:6631\u20136638. doi: 10.1172/JCI143120.", "ArticleIdList": ["10.1172/JCI143120", "PMC7685719", "32966269"]}, {"Citation": "Abdul-Rasool S., Fielding B.C. Understanding human Coronavirus. Open Virol. J. 2010;4:76\u201384. doi: 10.2174/1874357901004010076.", "ArticleIdList": ["10.2174/1874357901004010076", "PMC2918871", "20700397"]}, {"Citation": "Esper F., Weibel C., Ferguson D., Landry M.L., Kahn J.S. Coronavirus HKU1 infection in the United States. Emerg. Infect. Dis. 2006;12:775\u2013779. doi: 10.3201/eid1205.051316.", "ArticleIdList": ["10.3201/eid1205.051316", "PMC3374449", "16704837"]}, {"Citation": "Pene F., Merlat A., Vabret A., Rozenberg F., Buzyn A., Dreyfus F., Cariou A., Freymuth F., Lebon P. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin. Infect. Dis. 2003;37:929\u2013932. doi: 10.1086/377612.", "ArticleIdList": ["10.1086/377612", "PMC7107892", "13130404"]}, {"Citation": "Jordan P.C., Stevens S.K., Deval J. Nucleosides for the treatment of respiratory RNA virus infections. Antivir. Chem. Chemother. 2018;26:204020661876448. doi: 10.1177/2040206618764483.", "ArticleIdList": ["10.1177/2040206618764483", "PMC5890544", "29562753"]}, {"Citation": "Cevik M., Tate M., Lloyd O., Maraolo A.E., Schafers J., Ho A. SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: A living systematic review and meta-analysis. SSRN Electron. J. 2020 doi: 10.2139/ssrn.3677918.", "ArticleIdList": ["10.2139/ssrn.3677918", "PMC7837230", "33521734"]}, {"Citation": "Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450\u2013452. doi: 10.1038/s41591-020-0820-9.", "ArticleIdList": ["10.1038/s41591-020-0820-9", "PMC7095063", "32284615"]}, {"Citation": "Rabaan A.A., Al-Ahmed S.H., Haque S., Sah R., Tiwari R., Malik Y.S., Dhama K., Yatoo M.I., Bonilla-Aldana D.K., Rodriguez-Morales A.J. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez. Med. 2020;28:174\u2013184.", "ArticleIdList": ["32275259"]}, {"Citation": "Peeri N.C., Shrestha N., Rahman M.S., Zaki R., Tan Z., Bibi S., Baghbanzadeh M., Aghamohammadi N., Zhang W., Haque U. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? Int. J. Epidemiol. 2020;49:717\u2013726. doi: 10.1093/ije/dyaa033.", "ArticleIdList": ["10.1093/ije/dyaa033", "PMC7197734", "32086938"]}, {"Citation": "Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H., Jureka A.S., Obernier K., Guo J.Z., Batra J., et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370:eabe9403. doi: 10.1126/science.abe9403.", "ArticleIdList": ["10.1126/science.abe9403", "PMC7808408", "33060197"]}, {"Citation": "Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O., Pohlmann S. TMPRSS2 and ADAM17 Cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 2013;88:1293\u20131307. doi: 10.1128/JVI.02202-13.", "ArticleIdList": ["10.1128/JVI.02202-13", "PMC3911672", "24227843"]}, {"Citation": "Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011\u20131033. doi: 10.3390/v4061011.", "ArticleIdList": ["10.3390/v4061011", "PMC3397359", "22816037"]}, {"Citation": "Hulswit R.J.G., de Haan C.A.M., Bosch B.J. Coronavirus spike protein and tropism changes. Adv. Virus Res. 2016;96:29\u201357.", "ArticleIdList": ["PMC7112277", "27712627"]}, {"Citation": "Kirchdoerfer R.N., Cottrell C.A., Wang N., Pallesen J., Yassine H.M., Turner H.L., Corbett K.S., Graham B.S., McLellan J.S., Ward A.B. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531:118\u2013121. doi: 10.1038/nature17200.", "ArticleIdList": ["10.1038/nature17200", "PMC4860016", "26935699"]}, {"Citation": "Pillay T.S. Gene of the month: The 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. J. Clin. Pathol. 2020;73:366\u2013369. doi: 10.1136/jclinpath-2020-206658.", "ArticleIdList": ["10.1136/jclinpath-2020-206658", "32376714"]}, {"Citation": "Xia S., Liu M., Wang C., Xu W., Lan Q., Feng S., Qi F., Bao L., Du L., Liu S., et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30:343\u2013355. doi: 10.1038/s41422-020-0305-x.", "ArticleIdList": ["10.1038/s41422-020-0305-x", "PMC7104723", "32231345"]}, {"Citation": "Roviello V., Musumeci D., Mokhir A., Roviello G.N. Evidence of protein binding by a nucleopeptide based on a thymine-decorated L-diaminopropanoic acid through CD and in silico studies. Curr. Med. Chem. 2021 doi: 10.2174/0929867328666210201152326.", "ArticleIdList": ["10.2174/0929867328666210201152326", "33593247"]}, {"Citation": "Kim C.-H. SARS-CoV-2 evolutionary adaptation toward host entry and recognition of receptor O-acetyl sialylation in virus\u2013host interaction. Int. J. Mol. Sci. 2020;21:4549. doi: 10.3390/ijms21124549.", "ArticleIdList": ["10.3390/ijms21124549", "PMC7352545", "32604730"]}, {"Citation": "Artese A., Svicher V., Costa G., Salpini R., Di Maio V.C., Alkhatib M., Ambrosio F.A., Santoro M.M., Assaraf Y.G., Alcaro S., et al. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist. Updates. 2020;53:100721. doi: 10.1016/j.drup.2020.100721.", "ArticleIdList": ["10.1016/j.drup.2020.100721", "PMC7448791", "33132205"]}, {"Citation": "Schoeman D., Fielding B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0.", "ArticleIdList": ["10.1186/s12985-019-1182-0", "PMC6537279", "31133031"]}, {"Citation": "Chen B., Tian E.-K., He B., Tian L., Han R., Wang S., Xiang Q., Zhang S., El Arnaout T., Cheng W. Overview of lethal human coronaviruses. Signal Transduct. Target. Ther. 2020;5:89. doi: 10.1038/s41392-020-0190-2.", "ArticleIdList": ["10.1038/s41392-020-0190-2", "PMC7289715", "32533062"]}, {"Citation": "Cucinotta D., Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157\u2013160.", "ArticleIdList": ["PMC7569573", "32191675"]}, {"Citation": "Mercatelli D., Holding A.N., Giorgi F.M. Web tools to fight pandemics: The COVID-19 experience. Brief. Bioinform. 2020:bbaa261. doi: 10.1093/bib/bbaa261.", "ArticleIdList": ["10.1093/bib/bbaa261", "PMC7665357", "33057582"]}, {"Citation": "Arthi V., Parman J. Disease, downturns, and wellbeing: Economic history and the long-run impacts of COVID-19. Explorat. Econ. History. 2020:101381.", "ArticleIdList": ["PMC7606070", "33162564"]}, {"Citation": "Roviello V., Roviello G.N. Lower COVID-19 mortality in Italian forested areas suggests immunoprotection by Mediterranean plants. Environ. Chem. Lett. 2020;19:699\u2013710. doi: 10.1007/s10311-020-01063-0.", "ArticleIdList": ["10.1007/s10311-020-01063-0", "PMC7427271", "32837486"]}, {"Citation": "Ibn-Mohammed T., Mustapha K.B., Godsell J., Adamu Z., Babatunde K.A., Akintade D.D., Acquaye A., Fujii H., Ndiaye M.M., Yamoah F.A., et al. A critical analysis of the impacts of COVID-19 on the global economy and ecosystems and opportunities for circular economy strategies. Resour. Conserv. Recycl. 2021;164:105169. doi: 10.1016/j.resconrec.2020.105169.", "ArticleIdList": ["10.1016/j.resconrec.2020.105169", "PMC7505605", "32982059"]}, {"Citation": "Naveja J.J., Madariaga-Maz\u00f3n A., Flores-Murrieta F., Granados-Montiel J., Maradiaga-Cece\u00f1a M., Alaniz V.D., Maldonado-Rodriguez M., Garc\u00eda-Morales J., Senosiain-Pel\u00e1ez J.P., Mart\u00ednez-Mayorga K. Union is strength: Antiviral and anti-inflammatory drugs for COVID-19. Drug Disc. Today. 2020;26:229\u2013239. doi: 10.1016/j.drudis.2020.10.018.", "ArticleIdList": ["10.1016/j.drudis.2020.10.018", "PMC7590638", "33127568"]}, {"Citation": "Zhang W., Zhao Y., Zhang F., Wang Q., Li T., Liu Z., Wang J., Qin Y., Zhang X., Yan X. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin. Immunol. 2020;214:108393. doi: 10.1016/j.clim.2020.108393.", "ArticleIdList": ["10.1016/j.clim.2020.108393", "PMC7102614", "32222466"]}, {"Citation": "Costanzo M., De Giglio M.A.R., Roviello G.N. SARS CoV-2: Recent reports on antiviral therapies Based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Curr. Med. Chem. 2020;27:4536\u20134541. doi: 10.2174/0929867327666200416131117.", "ArticleIdList": ["10.2174/0929867327666200416131117", "32297571"]}, {"Citation": "Singh T.U., Parida S., Lingaraju M.C., Kesavan M., Kumar D., Singh R.K. Drug repurposing approach to fight COVID-19. Pharmacol. Rep. 2020;72:1479\u20131508. doi: 10.1007/s43440-020-00155-6.", "ArticleIdList": ["10.1007/s43440-020-00155-6", "PMC7474498", "32889701"]}, {"Citation": "Borbone N., Piccialli G., Roviello G.N., Oliviero G. Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses. Molecules. 2021;26:986. doi: 10.3390/molecules26040986.", "ArticleIdList": ["10.3390/molecules26040986", "PMC7918729", "33668428"]}, {"Citation": "Ang L., Lee H.W., Choi J.Y., Zhang J., Lee M.S. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines. Integr. Med. Res. 2020;9:100407. doi: 10.1016/j.imr.2020.100407.", "ArticleIdList": ["10.1016/j.imr.2020.100407", "PMC7104236", "32289016"]}, {"Citation": "Li Y., Liu X., Guo L., Li J., Zhong D., Zhang Y., Clarke M., Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta-analysis. Syst. Rev. 2020;9:1\u20136. doi: 10.1186/s13643-020-01343-4.", "ArticleIdList": ["10.1186/s13643-020-01343-4", "PMC7138957", "32268923"]}, {"Citation": "Ang L., Lee H.W., Kim A., Lee J.A., Zhang J., Lee M.S. Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines. Complement. Ther. Clin. Pract. 2020;14:101174. doi: 10.1016/j.ctcp.2020.101174.", "ArticleIdList": ["10.1016/j.ctcp.2020.101174", "PMC7152923", "32379639"]}, {"Citation": "Shahrajabian M.H., Sun W., Shen H., Cheng Q. Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak. Acta Agric. Scand. Sect. B Soil Plant Sci. 2020;70:437\u2013443. doi: 10.1080/09064710.2020.1763448.", "ArticleIdList": ["10.1080/09064710.2020.1763448"]}, {"Citation": "Lee D.Y., Li Q.Y., Liu J., Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Phytomedicine. 2021;80:153337. doi: 10.1016/j.phymed.2020.153337.", "ArticleIdList": ["10.1016/j.phymed.2020.153337", "PMC7521884", "33221457"]}, {"Citation": "Wei H., Liu S., Liao Y., Ma C., Wang D., Tong J., Feng J., Yi T., Zhu L. A systematic review of the medicinal potential of mulberry in treating diabetes mellitus. Am. J. Chin. Med. 2019;46:1743\u20131770. doi: 10.1142/S0192415X1850088X.", "ArticleIdList": ["10.1142/S0192415X1850088X", "30518235"]}, {"Citation": "Ng K.-W., Cao Z.-J., Chen H.-B., Zhao Z.-Z., Zhu L., Yi T. Oolong tea: A critical review of processing methods, chemical composition, health effects, and risk. Crit. Rev. Food Sci. Nutr. 2017;58:2957\u20132980. doi: 10.1080/10408398.2017.1347556.", "ArticleIdList": ["10.1080/10408398.2017.1347556", "28678527"]}, {"Citation": "Yi T., Chen H.-B., Zhao Z.-Z., Yu Z.-L., Jiang Z.-H. Comparison of the chemical profiles and anti-platelet aggregation effects of two \u201cDragon\u2019s Blood\u201d drugs used in traditional Chinese medicine. J. Ethnopharmacol. 2011;133:796\u2013802. doi: 10.1016/j.jep.2010.11.008.", "ArticleIdList": ["10.1016/j.jep.2010.11.008", "21073937"]}, {"Citation": "Yi T., Tang Y., Zhang J., Zhao Z., Yang Z., Chen H. Characterization and determination of six flavonoids in the ethnomedicine \u201cDragon\u2019s Blood\u201d by UPLC-PAD-MS. Chem. Cent. J. 2012;6:116. doi: 10.1186/1752-153X-6-116.", "ArticleIdList": ["10.1186/1752-153X-6-116", "PMC3505180", "23050850"]}, {"Citation": "Xue Y., Zhu L., Yi T. Fingerprint analysis of Resina Draconis by ultra-performance liquid chromatography. Chem. Cent. J. 2017;11 doi: 10.1186/s13065-017-0299-8.", "ArticleIdList": ["10.1186/s13065-017-0299-8", "PMC5524661", "29086860"]}, {"Citation": "Zheng G.-Q., Kenney P.M., Lam L.K. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod. 1992;55:999\u20131003. doi: 10.1021/np50085a029.", "ArticleIdList": ["10.1021/np50085a029", "1402962"]}, {"Citation": "Bhowmik D., Kumar K.S., Yadav A., Srivastava S., Paswan S., Dutta A.S. Recent trends in Indian traditional herbs Syzygium aromaticum and its health benefits. J. Pharm. Phytochem. 2012;1:13\u201322."}, {"Citation": "Cort\u00e9s-Rojas D.F., de Souza C.R.F., Oliveira W.P. Clove (Syzygium aromaticum): A precious spice. Asian Pac. J. Trop. Biomed. 2014;4:90\u201396. doi: 10.1016/S2221-1691(14)60215-X.", "ArticleIdList": ["10.1016/S2221-1691(14)60215-X", "PMC3819475", "25182278"]}, {"Citation": "Aisha A.F., Abu-Salah K.M., Alrokayan S.A., Siddiqui M.J., Ismail Z., Majid A.M.S.A. Syzygium aromaticum extracts as good source of betulinic acid and potential anti-breast cancer. Rev. Bras. Farm. 2012;22:335\u2013343. doi: 10.1590/S0102-695X2011005000185.", "ArticleIdList": ["10.1590/S0102-695X2011005000185"]}, {"Citation": "Prashar A., Locke I.C., Evans C.S. Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells. Cell Prolif. 2006;39:241\u2013248. doi: 10.1111/j.1365-2184.2006.00384.x.", "ArticleIdList": ["10.1111/j.1365-2184.2006.00384.x", "PMC6496679", "16872360"]}, {"Citation": "Banerjee S., Panda C.K., Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis. 2006;27:1645\u20131654. doi: 10.1093/carcin/bgi372.", "ArticleIdList": ["10.1093/carcin/bgi372", "16501250"]}, {"Citation": "Aisha A., Nassar Z., Siddiqui M., Abu-Salah K., Alrokayan S., Ismail Z., Abdul Majid A. Evaluation of antiangiogenic, cytotoxic and antioxidant effects of Syzygium aromaticum L. extracts. Asian J. Biol. Sci. 2011;4:282\u2013290. doi: 10.3923/ajbs.2011.282.290.", "ArticleIdList": ["10.3923/ajbs.2011.282.290"]}, {"Citation": "Ogata M., Hoshi M., Urano S., Endo T. Antioxidant activity of eugenol and related monomeric and dimeric compounds. Chem. Pharm. Bull. 2000;48:1467\u20131469. doi: 10.1248/cpb.48.1467.", "ArticleIdList": ["10.1248/cpb.48.1467", "11045452"]}, {"Citation": "Darshan S., Doreswamy R. Patented antiinflammatory plant drug development from traditional medicine. Phytother. Res. 2004;18:343\u2013357. doi: 10.1002/ptr.1475.", "ArticleIdList": ["10.1002/ptr.1475", "15173991"]}, {"Citation": "Miyazawa M., Hisama M. Suppression of chemical mutagen-induced SOS response by alkylphenols from clove (Syzygium aromaticum) in the Salmonella typhimurium TA1535/pSK1002 umu test. J. Agric. Food Chem. 2001;49:4019\u20134025. doi: 10.1021/jf0103469.", "ArticleIdList": ["10.1021/jf0103469", "11513704"]}, {"Citation": "Vijayasteltar L., Nair G.G., Maliakel B., Kuttan R., Krishnakumar I. Safety assessment of a standardized polyphenolic extract of clove buds: Subchronic toxicity and mutagenicity studies. Toxicol. Rep. 2016;3:439\u2013449. doi: 10.1016/j.toxrep.2016.04.001.", "ArticleIdList": ["10.1016/j.toxrep.2016.04.001", "PMC5615916", "28959566"]}, {"Citation": "Ogunwande I., Olawore N., Ekundayo O., Walker T., Schmidt J., Setzer W. Studies on the essential oils composition, antibacterial and cytotoxicity of Eugenia uniflora L. Int. J. Aromather. 2005;15:147\u2013152. doi: 10.1016/j.ijat.2005.07.004.", "ArticleIdList": ["10.1016/j.ijat.2005.07.004"]}, {"Citation": "Udensi U.K., Tchounwou P.B. Potassium homeostasis, oxidative stress, and human disease. Int. J. Clin. Exp. Physiol. 2017;4:111.", "ArticleIdList": ["PMC5716641", "29218312"]}, {"Citation": "Horsburgh M.J., Wharton S.J., Karavolos M., Foster S.J. Manganese: Elemental defence for a life with oxygen. Trends Microbiol. 2002;10:496\u2013501. doi: 10.1016/S0966-842X(02)02462-9.", "ArticleIdList": ["10.1016/S0966-842X(02)02462-9", "12419613"]}, {"Citation": "Fang S., Thomas R.M., Conklin J.L., Oberley L.W., Christensen J. Co-localization of manganese superoxide dismutase and NADH diaphorase. J. Histochem. Cytochem. 1995;43:849\u2013855. doi: 10.1177/43.8.7622845.", "ArticleIdList": ["10.1177/43.8.7622845", "7622845"]}, {"Citation": "Cao Y., Qin Y., Bruist M., Gao S., Wang B., Wang H., Guo X. Formation and dissociation of the interstrand i-motif by the sequences d(XnC4Ym) monitored with electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 2015;26:994\u20131003. doi: 10.1007/s13361-015-1093-2.", "ArticleIdList": ["10.1007/s13361-015-1093-2", "25862186"]}, {"Citation": "Wilson J.X. Mechanism of action of vitamin C in sepsis: Ascorbate modulates redox signaling in endothelium. Biofactors. 2009;35:5\u201313. doi: 10.1002/biof.7.", "ArticleIdList": ["10.1002/biof.7", "PMC2767105", "19319840"]}, {"Citation": "Bagchi D., Garg A., Krohn R., Bagchi M., Tran M., Stohs S. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Commun. Mol. Pathol. Pharmacol. 1997;95:179\u2013189.", "ArticleIdList": ["9090754"]}, {"Citation": "Pino J.A., Marbot R., Ag\u00fcero J., Fuentes V. Essential oil from buds and leaves of clove (Syzygium aromaticum (L.) Merr. et Perry) grown in Cuba. J. Essent. Oil Res. 2001;13:278\u2013279. doi: 10.1080/10412905.2001.9699693.", "ArticleIdList": ["10.1080/10412905.2001.9699693"]}, {"Citation": "Raina V., Srivastava S., Aggarwal K., Syamasundar K., Kumar S. Essential oil composition of Syzygium aromaticum leaf from Little Andaman, India. Flavour Fragr. J. 2001;16:334\u2013336. doi: 10.1002/ffj.1005.", "ArticleIdList": ["10.1002/ffj.1005"]}, {"Citation": "Zachariah T., Krishnamoorthy B., Rema J., Mathew P. Oil constituents in bud and pedicel of clove (Syzygium aromaticum) Ind. Perf. 2005;49:313."}, {"Citation": "Mittal M., Gupta N., Parashar P., Mehra V., Khatri M. Phytochemical evaluation and pharmacological activity of Syzygium aromaticum: A comprehensive review. Int. J. Pharm. Pharm. Sci. 2014;6:67\u201372."}, {"Citation": "Jimoh S.O., Arowolo L.A., Alabi K.A. Phytochemical screening and antimicrobial evaluation of Syzygium aromaticum extract and essential oil. Int. J. Curr. Microbiol. Appl. Sci. 2017;6:4557\u20134567. doi: 10.20546/ijcmas.2017.607.476.", "ArticleIdList": ["10.20546/ijcmas.2017.607.476"]}, {"Citation": "El Ghallab Y., Al Jahid A., Eddine J.J., Said A.A.H., Zarayby L., Derfoufi S. Syzygium aromaticum L.: Phytochemical investigation and comparison of the scavenging activity of essential oil, extracts and eugenol. Adv. Tradit. Med. 2020;20:153\u2013158. doi: 10.1007/s13596-019-00416-7.", "ArticleIdList": ["10.1007/s13596-019-00416-7"]}, {"Citation": "Begum S., Siddiqui B.S., Khatoon R., Aftab F. Phytochemical studies on Syzygium aromaticum Linn. J. Chem. Soc. Pak. 2014;36:512."}, {"Citation": "Chaieb K., Hajlaoui H., Zmantar T., Kahla-Nakbi A.B., Rouabhia M., Mahdouani K., Bakhrouf A. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): A short review. Phytother. Res. 2007;21:501\u2013506. doi: 10.1002/ptr.2124.", "ArticleIdList": ["10.1002/ptr.2124", "17380552"]}, {"Citation": "Gopalakrishnan N., Narayanan C., Mathew A. Sesquiterpene hydrocarbons from clove oil. Lebensmittel-Wissenschaft+ Technol. 1984;17:42\u201343."}, {"Citation": "Zhao C., Qiao X., Shao Q., Hassan M., Ma Z. Evolution of the lignin chemical structure during the bioethanol production process and its inhibition to enzymatic hydrolysis. Energy Fuels. 2020;34:5938\u20135947. doi: 10.1021/acs.energyfuels.0c00293.", "ArticleIdList": ["10.1021/acs.energyfuels.0c00293"]}, {"Citation": "Frohlich P.C., Santos K.A., Pal\u00fa F., Cardozo-Filho L., da Silva C., da Silva E.A. Evaluation of the effects of temperature and pressure on the extraction of eugenol from clove (Syzygium aromaticum) leaves using supercritical CO2. J. Supercrit. Fluids. 2019;143:313\u2013320. doi: 10.1016/j.supflu.2018.09.009.", "ArticleIdList": ["10.1016/j.supflu.2018.09.009"]}, {"Citation": "Bahramsoltani R., Rahimi R. An evaluation of traditional Persian medicine for the management of SARS-CoV-2. Front. Pharmacol. 2020;11 doi: 10.3389/fphar.2020.571434.", "ArticleIdList": ["10.3389/fphar.2020.571434", "PMC7724033", "33324206"]}, {"Citation": "\u00d6zt\u00fcrk A., \u00d6zbek H. The anti-inflammatory activity of Eugenia caryophyllata essential oil: An animal model of anti-inflammatory activity. Eur. J. Gen Med. 2005;2:159\u2013163."}, {"Citation": "Tanko Y., Mohammed A., Okasha M., Umah A., Magaji R. Anti-nociceptive and anti-inflammatory activities of ethanol extract of Syzygium aromaticum flower bud in wistar rats and mice. Afr. J. Trad. Complement. Altern. Med. 2008;5:209\u2013212. doi: 10.4314/ajtcam.v5i2.31275.", "ArticleIdList": ["10.4314/ajtcam.v5i2.31275", "PMC2816534", "20161939"]}, {"Citation": "Martin S., Padilla E., Ocete M., Galvez J., Jimenez J., Zarzuelo A. Anti-inflammatory activity of the essential oil of Bupleurum fruticescens. Planta Med. 1993;59:533\u2013536. doi: 10.1055/s-2006-959755.", "ArticleIdList": ["10.1055/s-2006-959755", "8302953"]}, {"Citation": "Rho H.S., Ghimeray A.K., Yoo D.S., Ahn S.M., Kwon S.S., Lee K.H., Cho D.H., Cho J.Y. Kaempferol and kaempferol rhamnosides with depigmenting and anti-inflammatory properties. Molecules. 2011;16:3338\u20133344. doi: 10.3390/molecules16043338.", "ArticleIdList": ["10.3390/molecules16043338", "PMC6260593", "21512441"]}, {"Citation": "Garc\u00eda-Mediavilla V., Crespo I., Collado P.S., Esteller A., S\u00e1nchez-Campos S., Tu\u00f1\u00f3n M.J., Gonz\u00e1lez-Gallego J. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur. J. Pharmacol. 2007;557:221\u2013229. doi: 10.1016/j.ejphar.2006.11.014.", "ArticleIdList": ["10.1016/j.ejphar.2006.11.014", "17184768"]}, {"Citation": "Jnawali H.N., Lee E., Jeong K.-W., Shin A., Heo Y.-S., Kim Y. Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK. J. Nat. Prod. 2014;77:258\u2013263. doi: 10.1021/np400803n.", "ArticleIdList": ["10.1021/np400803n", "24397781"]}, {"Citation": "Novo Belchor M., Hessel Gaeta H., Fabri Bittencourt Rodrigues C., Ramos da Cruz Costa C., de Oliveira Toyama D., Domingues Passero L.F., Dalastra Laurenti M., Hikari Toyama M. Evaluation of rhamnetin as an inhibitor of the pharmacological effect of secretory phospholipase A2. Molecules. 2017;22:1441. doi: 10.3390/molecules22091441.", "ArticleIdList": ["10.3390/molecules22091441", "PMC6151830", "28858248"]}, {"Citation": "Daniel A.N., Sartoretto S.M., Schmidt G., Caparroz-Assef S.M., Bersani-Amado C.A., Cuman R.K.N. Anti-inflammatory and antinociceptive activities A of eugenol essential oil in experimental animal models. Rev. Bras. Farm. 2009;19:212\u2013217. doi: 10.1590/S0102-695X2009000200006.", "ArticleIdList": ["10.1590/S0102-695X2009000200006"]}, {"Citation": "Magalh\u00e3es C.B., Riva D.R., DePaula L.J., Brando-Lima A., Koatz V.L.G., Leal-Cardoso J.H., Zin W.A., Faffe D.S. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J. Appl. Physiol. 2010;108:845\u2013851. doi: 10.1152/japplphysiol.00560.2009.", "ArticleIdList": ["10.1152/japplphysiol.00560.2009", "20075264"]}, {"Citation": "Chniguir A., Zioud F., Marzaioli V., El-Benna J., Bachoual R. Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation. Pharm. Biol. 2019;57:55\u201363. doi: 10.1080/13880209.2018.1557697.", "ArticleIdList": ["10.1080/13880209.2018.1557697", "PMC6366422", "30707845"]}, {"Citation": "Nassan M., Mohamed E., Abdelhafez S., Ismail T. Effect of clove and cinnamon extracts on experimental model of acute hematogenous pyelonephritis in albino rats: Immunopathological and antimicrobial study. Int. J. Immunopathol. Pharmacol. 2015;28:60\u201368. doi: 10.1177/0394632015572075.", "ArticleIdList": ["10.1177/0394632015572075", "25816407"]}, {"Citation": "Su H., Yang M., Wan C., Yi L.-X., Tang F., Zhu H.-Y., Yi F., Yang H.-C., Fogo A.B., Nie X. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219\u2013227. doi: 10.1016/j.kint.2020.04.003.", "ArticleIdList": ["10.1016/j.kint.2020.04.003", "PMC7194105", "32327202"]}, {"Citation": "Carrasco F.R., Schmidt G., Romero A.L., Sartoretto J.L., Caparroz-Assef S.M., Bersani-Amado C.A., Cuman R.K.N. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: Evidence for humor-and cell-mediated responses. J. Pharm. Pharmacol. 2009;61:961\u2013967. doi: 10.1211/jpp/61.07.0017.", "ArticleIdList": ["10.1211/jpp/61.07.0017", "19589240"]}, {"Citation": "Saeed S.A., Gilani A.H. Antithrombotic activity of clove oil. J. Pak. Med. Assoc. 1994;44:112.", "ArticleIdList": ["8078176"]}, {"Citation": "Yang Y.-Y., Lee M.-J., Lee H.-S., Park W.-H. Screening of antioxidative, anti-platelet aggregation and anti-thrombotic effects of clove extracts. J. Physiol. Pathol. Korean Med. 2011;25:471\u2013481."}, {"Citation": "Rasheed A., Laekeman G., Totte J., Vlietinck A., Herman A. Eugenol and prostaglandin biosynthesis. N. Engl. J. Med. 1984;310:50\u201351.", "ArticleIdList": ["6689743"]}, {"Citation": "Srivastava K. Antiplatelet principles from a food spice clove (Syzgium aromaticum L) Prostag. Leukot. Essent. Fat. Acids. 1993;48:363\u2013372. doi: 10.1016/0952-3278(93)90116-E.", "ArticleIdList": ["10.1016/0952-3278(93)90116-E", "8321872"]}, {"Citation": "Im LEE J., Lee H.S., Jun W.J., Yu K.W., Shin D.H., Hong B.S., Cho H.Y., Yang H.C. Purification and Characterization of Antithrombotics from Syzygium aromaticum (L.) MERR. & PERRY. Biol. and Pharm. Bull. 2001;24:181\u2013187. doi: 10.1248/bpb.24.181.", "ArticleIdList": ["10.1248/bpb.24.181", "11217089"]}, {"Citation": "Tragoolpua Y., Jatisatienr A. Anti-herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & SG Harrison and essential oil, eugenol. Phytother. Res. 2007;21:1153\u20131158.", "ArticleIdList": ["17628885"]}, {"Citation": "Hussein G., Miyashiro H., Nakamura N., Hattori M., Kakiuchi N., Shimotohno K. Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother. Res. 2000;14:510\u2013516. doi: 10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B.", "ArticleIdList": ["10.1002/1099-1573(200011)14:7<510::AID-PTR646>3.0.CO;2-B", "11054840"]}, {"Citation": "Benencia F., Courreges M. In vitro and in vivo activity of eugenol on human herpesvirus. Phytother. Res. 2000;14:495\u2013500. doi: 10.1002/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8.", "ArticleIdList": ["10.1002/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8", "11054837"]}, {"Citation": "Dai J.-P., Zhao X.-F., Zeng J., Wan Q.-Y., Yang J.-C., Li W.-Z., Chen X.-X., Wang G.-F., Li K.-S. Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity. PLoS ONE. 2013;8:e61026. doi: 10.1371/journal.pone.0061026.", "ArticleIdList": ["10.1371/journal.pone.0061026", "PMC3628889", "23613775"]}, {"Citation": "Lane T., Anantpadma M., Freundlich J.S., Davey R.A., Madrid P.B., Ekins S. The natural product eugenol is an inhibitor of the ebola virus in vitro. Pharm. Res. 2019;36:1\u20136. doi: 10.1007/s11095-019-2629-0.", "ArticleIdList": ["10.1007/s11095-019-2629-0", "PMC6668022", "31101988"]}, {"Citation": "Kurokawa M., Hozumi T., Basnet P., Nakano M., Kadota S., Namba T., Kawana T., Shiraki K. Purification and Characterization of Eugeniin as an Anti-herpesvirus Compound from Geum japonicum and Syzygium aromaticum. J. Pharmacol. Exp. Ther. 1998;284:728\u2013735.", "ArticleIdList": ["9454821"]}, {"Citation": "Saleem H.N., Batool F., Mansoor H.J., Shahzad-ul-Hussan S., Saeed M. Inhibition of dengue virus protease by Eugeniin, Isobiflorin, and Biflorin Isolated from the Flower Buds of Syzygium aromaticum (Cloves) ACS Omega. 2019;4:1525\u20131533. doi: 10.1021/acsomega.8b02861.", "ArticleIdList": ["10.1021/acsomega.8b02861"]}, {"Citation": "Kanyinda J.N.M. Coronavirus (COVID-19): A protocol for prevention and treatment (Covalyse\u00ae) Eur. J. Med. Health Sci. 2020;2:1\u20134. doi: 10.24018/ejmed.2020.2.4.340.", "ArticleIdList": ["10.24018/ejmed.2020.2.4.340"]}, {"Citation": "Samaddar A., Gadepalli R., Nag V.L., Misra S. The enigma of low COVID-19 fatality rate in India. Front. Genet. 2020;11:854. doi: 10.3389/fgene.2020.00854.", "ArticleIdList": ["10.3389/fgene.2020.00854", "PMC7399343", "32849833"]}, {"Citation": "Rhodes J.M., Subramanian S., Laird E., Kenny R.A. Low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment. Pharmacol. Ther. 2020;51:1434\u20131437. doi: 10.1111/apt.15777.", "ArticleIdList": ["10.1111/apt.15777", "PMC7264531", "32311755"]}, {"Citation": "Singh N.A., Kumar P., Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother. Res. 2021;29 doi: 10.1002/ptr.7019.", "ArticleIdList": ["10.1002/ptr.7019", "PMC8013177", "33511704"]}, {"Citation": "Chaachouay N., Douira A., Zidane L. COVID-19, prevention and treatment with herbal medicine in the herbal markets of Sal\u00e9 Prefecture, North-Western Morocco. Eur. J. Integrat. Med. 2021;42:101285. doi: 10.1016/j.eujim.2021.101285.", "ArticleIdList": ["10.1016/j.eujim.2021.101285", "PMC7836426", "33520016"]}, {"Citation": "Pandey P., Singhal D., Khan F., Arif M. An in silico screening on Piper nigrum, Syzygium aromaticum and Zingiber officinale roscoe derived compounds against SARS-CoV-2: A drug repurposing approach. Biointerface Res. Appl. Chem. 2020;11:11122\u201311134."}, {"Citation": "Joshi T., Joshi T., Sharma P., Mathpal S., Pundir H., Bhatt V., Chandra S. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur. Rev. Med. Pharmacol. Sci. 2020;24:4529\u20134536.", "ArticleIdList": ["32373991"]}, {"Citation": "Rehman M., AlAjmi M.F., Hussain A. Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro): A molecular docking and simulation approach to combat COVID-19. Curr. Pharm. Des. 2020;16 doi: 10.2174/1381612826999201116195851.", "ArticleIdList": ["10.2174/1381612826999201116195851", "33200697"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "8"}, {"Year": "2021", "Month": "3", "Day": "19"}, {"Year": "2021", "Month": "3", "Day": "22"}, {"Year": "2021", "Month": "4", "Day": "3", "Hour": "1", "Minute": "36"}, {"Year": "2021", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["33810416", "PMC8036487", "10.3390/molecules26071880", "molecules26071880"]}}], "PubmedBookArticle": []}